Jinfiniti Precision Medicine
- Company typePrivate
- Founded2018
- HeadquartersAugusta, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Jinfiniti Precision Medicine firmographics
Firmographics- Name
- Jinfiniti Precision Medicine
- Legal name
- Jinfiniti Precision Medicine, Inc.
- Website
- https://jinfiniti.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Jinfiniti Precision Medicine industry classification
Industry- Product category
- Longevity Supplements and Biomarker Testing
- NAICS
- Testing Laboratories and Services (54138), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Food (Health) Supplement Retailers (456191)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Healthy Aging & Cognitive Support Supplements (CRADAGAM)
Keywords
Where Jinfiniti Precision Medicine is headquartered
LocationHeadquarters
- HQ city
- Augusta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Jinfiniti Precision Medicine business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel, Infrastructure
Revenue model
- Biomarker Testing Kits: One-time purchase of at-home test kits including Intracellular NAD Test ($198), AgingSOS Advanced Panel ($1,198), and AgingSOS Ultimate Panel. Mobile blood draw service included with premium panels.
- NAD+ Optimization Membership: Subscription membership providing ongoing NAD+ optimization with free tests, savings on supplements, and guaranteed outcomes. Tiered program structure for different commitment levels.
- Supplements: One-time and subscription purchases of supplements including Vitality NAD+ Booster ($118), SenoAid Senolytic ($58), and other health products. Supplement sales often follow initial testing to address identified deficiencies.
- Affiliate Program: 10% sales commission for affiliates referring customers to jinfiniti.com. Average order value $300-$500 yielding $30-50 per referral.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | AgingSOS Advanced Panel - 28 biomarkers including NAD+ and Klotho |
| Unit Pricing | Pay-as-you-go | Intracellular NAD Test |
| Unit Pricing | Pay-as-you-go | Vitality NAD+ Booster Powder |
| Unit Pricing | Pay-as-you-go | SenoAid Senolytic Complex |
| Subscription | Monthly | NAD+ Optimization Membership |
| Unit Pricing | Pay-as-you-go | Creatine + ATP |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
Jinfiniti Precision Medicine product offering
Product offeringCore offering
Jinfiniti designs and sells at-home biomarker test kits (Intracellular NAD+ Test, AgingSOS Advanced and Ultimate Panels) combined with clinically validated supplements (Vitality NAD+ Booster, SenoAid Senolytic Complex, Creatine + ATP, Vitamin D3 + K2, Turmeric+). The portfolio is anchored by the TAO (Test, Act, Optimize) framework, which guides customers through baseline biomarker assessment, personalized intervention protocols based on test data, and continuous optimization via retesting. Products are sold primarily direct-to-consumer online, alongside a subscription-based NAD+ Optimization Membership and a B2B For Providers channel serving clinicians and wellness centers.
Product overview
Jinfiniti Precision Medicine offers a data-driven health optimization platform combining proprietary biomarker testing with science-backed supplement protocols. The core portfolio centers on the TAO (Test, Act, Optimize) framework: customers use at-home biomarker tests (Intracellular NAD® Test, AgingSOS® Advanced Panel, AgingSOS® Ultimate Panel) to establish baselines across 8 root-cause categories, then follow personalized protocols using targeted supplements (Vitality ↑® NAD+ Booster, SenoAid™ Senolytic Complex, Creatine + ATP, Vitamin D3 + K2, Extra Strength Turmeric+). The NAD+ Optimization Membership provides subscription-based testing and supplement access with guaranteed outcomes. Services include mobile blood draws, expert consultations, and continuous protocol refinement through retesting.
Differentiator
Problem solved
Functional benefit
Brands
- Vitality NAD+ Booster: NAD+ optimization supplement combining NMN, niacinamide, creatine monohydrate, and D-Ribose
- SenoAid
- AgingSOS Advanced Panel
- AgingSOS Ultimate Panel
- Intracellular NAD Test
Products and services
- Intracellular NAD+ Test CLIA-certified at-home finger-prick blood spot test measuring intracellular NAD+ levels in micromoles with results delivered within one week; priced at $198.
- AgingSOS Advanced Panel Comprehensive at-home longevity blood test tracking 28 biomarkers across cellular health, cardiovascular risk, metabolic function, and organ function, paired with a personalized report, expert consultation, and mobile blood draw service.
- AgingSOS Ultimate Panel Comprehensive 48-biomarker at-home panel covering 8 root-cause categories (micronutrient deficiencies, macronutrients/metabolism, inflammation, cellular senescence, oxidative stress, hormone imbalance, toxin accumulation, organ damage), with CLIA-certified labs, free expert consultation, and mobile blood draw.
- Vitality NAD+ Booster Patented multi-pathway NAD+ supplement combining NMN, Niacinamide, Creatine Monohydrate, and D-Ribose, clinically validated to increase NAD+ levels by 100%+ on average.
- SenoAid Senolytic Complex Extra-strength senolytic supplement combining quercetin and fisetin to clear senescent cells and support natural cell renewal.
- Creatine + ATP Dual-action powder formula combining pure creatine monohydrate with disodium ATP for brain health and cellular energy support.
- NAD+ Optimization Membership Subscription program providing ongoing NAD+ optimization with free tests, supplement savings, and guaranteed outcome-based protocols.
- Vitamin D3 + K2 Vitamin D3 supplement paired with the MK-7 form of K2 to direct calcium effectively and address micronutrient gaps common in postmenopausal women.
- Extra Strength Turmeric+ Anti-inflammatory turmeric/curcumin supplement supporting chronic inflammation management.
- At-Home Health Tests Curated collection of at-home biomarker testing services, including the Intracellular NAD+ Test, AgingSOS panels, and related health assessments delivered through mobile blood draw or finger-prick collection.
Quantifiable outcome
- 85% of participants reached optimal intracellular NAD+ levels (40-100 μM) within 4 weeks
- +2 more outcomes
Companies that use Jinfiniti Precision Medicine
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles2 records
Jinfiniti Precision Medicine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Jinfiniti Precision Medicine partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- EverflowminorAffiliate program management platform used to power Jinfiniti's affiliate marketing initiative. Allows tracking and management of affiliate partners earning 10% commission on referred sales.
Scale indicators9 records
Recent moves5 records
Expansion highlights5 records
Jinfiniti Precision Medicine competitors and assessment
Company assessmentDirect peers
- InsideTracker: InsideTracker offers at-home biomarker blood testing paired with personalized health and longevity recommendations, often including supplement suggestions. Directly comparable to Jinfiniti in combining proprietary panel testing with an action-oriented protocol layer for consumer and clinician audiences.
- Function Health: Function Health provides membership-based annual biomarker testing (100+ lab markers) focused on early detection and longevity optimization for consumers. Closely mirrors Jinfiniti's recurring-test-plus-action framework and is the most direct subscription-testing peer in the category.
- Thorne HealthTech: Thorne offers at-home health tests alongside an extensive clinical-grade supplement line, targeting both consumers and practitioners. The dual test-and-supplement model and clinician channel overlap make it a strong direct peer to Jinfiniti's integrated platform.
- Elysium Health: Elysium Health commercializes NAD+ and longevity supplements (Basis/NR) grounded in published clinical research. Overlaps directly with Jinfiniti's NAD+ booster supplement line and longevity positioning, though it leans more on supplements and less on diagnostic testing.
- TruDiagnostic: TruDiagnostic provides epigenetic and biological age testing, including methylation-based longevity biomarkers. Comparable to Jinfiniti's AgingSOS panels in offering advanced biomarker testing for healthspan consumers and clinicians.
- Tally Health: Tally Health sells at-home biological age testing (TallyAge) paired with longevity supplements. Competes in the same test-plus-supplement DTC longevity category as Jinfiniti, targeting health-conscious consumers with premium pricing.
- Viome Life Sciences: Viome offers at-home microbiome and cellular health testing with personalized nutrition and supplement recommendations. Comparable business model to Jinfiniti in coupling proprietary at-home diagnostics with personalized intervention products sold DTC.
- Life Extension: Life Extension is a long-standing retailer of longevity-focused supplements and blood testing services. Overlaps with Jinfiniti in the consumer longevity category, combining lab testing access with a deep supplement catalog.
Emerging players
- Superpower: Superpower is a venture-backed at-home biomarker testing platform focused on annual health panels for proactive consumers. Closely aligned with Jinfiniti's DTC longevity testing thesis and is a meaningful emerging competitor in the subscription-testing category.
- Novos Labs: Novos develops longevity supplement stacks based on aging biology research and sells DTC with scientific positioning. Overlaps with Jinfiniti's supplement line (e.g., SenoAid senolytics) but focuses on supplements rather than biomarker diagnostics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks1 record
Key highlights7 records
Customer concentration
Jinfiniti Precision Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jinfiniti Precision Medicine leadership team
Management profileNumber of profiles
Profiles1 record
Jinfiniti Precision Medicine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jinfiniti Precision Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jinfiniti Precision Medicine
What does Jinfiniti Precision Medicine do?
Jinfiniti designs and sells at-home biomarker test kits (Intracellular NAD+ Test, AgingSOS Advanced and Ultimate Panels) combined with clinically validated supplements (Vitality NAD+ Booster, SenoAid Senolytic Complex, Creatine + ATP, Vitamin D3 + K2, Turmeric+). The portfolio is anchored by the TAO (Test, Act, Optimize) framework, which guides customers through baseline biomarker assessment, personalized intervention protocols based on test data, and continuous optimization via retesting. Products are sold primarily direct-to-consumer online, alongside a subscription-based NAD+ Optimization Membership and a B2B For Providers channel serving clinicians and wellness centers.
Is Jinfiniti Precision Medicine a public or private company?
Jinfiniti Precision Medicine is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Jinfiniti Precision Medicine founded?
Jinfiniti Precision Medicine was founded in 2018. It employs 1 to 10 people.
Where is Jinfiniti Precision Medicine based?
Jinfiniti Precision Medicine is headquartered in Augusta, United States, in the North America region.
How does Jinfiniti Precision Medicine make money?
Four revenue lines are on record. Biomarker Testing Kits are the primary driver. The others are NAD+ Optimization Membership, supplements and affiliate Program.
Who are Jinfiniti Precision Medicine's main competitors?
Direct peers on record are InsideTracker, Function Health, Thorne HealthTech, Elysium Health, TruDiagnostic, Tally Health, Viome Life Sciences and Life Extension. Emerging players are Superpower and Novos Labs.
Does Jinfiniti Precision Medicine have an API?
No public API is recorded for Jinfiniti Precision Medicine.
What industry is Jinfiniti Precision Medicine in?
Jinfiniti Precision Medicine's product category is Longevity Supplements and Biomarker Testing. Its primary akta.pro industry code is HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 54138 and its SIC code is 8071.